MetLife Investment Advisors »

Protara Therapeutic shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Protara Therapeutic (TARA) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Protara Therapeutic

Tip: Access up to 7 years of quarterly data

All positions including Protara Therapeutic held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protara Therapeutic by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $23k 4.4k 5.33

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A Cap Stk Cl (GOOGL)
Broadcom (AVGO)
Meta Platforms Inc Class A Cl A (META)
Alphabet Inc Class C Cap Stk Cl (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm (BSV)
Visa Inc Class A Com Cl A (V)
Spdr S&p Etf Trust Tr Unit (SPY)

View all positions for MetLife Investment Advisors

Top funds holding Protara Therapeutic

Henderson Group
Velan Capital Investment Management
BlackRock
Vanguard Group
Integral Health Asset Management
Blackstone Group
Acorn Capital Advisors
Catalio Capital Management
5AM Venture Management
UBS Group
ADAR1 Capital Management
Geode Capital Management
Maven Securities
Millennium Management
Sphera Funds Management

View all funds holding Protara Therapeutic